Valuation: Sagittarius Life Science Corp

Market Cap 311.72Cr 9.56Cr 8.54Cr 7.89Cr 7.15Cr 13Cr 907.83Cr 14Cr 95Cr 38Cr 475.64Cr 36Cr 35Cr 1.5TCr P/E 2024
-21.4x
P/E 2025 -55.9x
Enterprise Value 231.41Cr 7.1Cr 6.34Cr 5.86Cr 5.31Cr 9.93Cr 673.93Cr 10Cr 70Cr 28Cr 353.09Cr 27Cr 26Cr 1.11TCr EV / Sales 2024
1.9x
EV / Sales 2025 7.69x
Free-Float
29.82%
Yield 2024 *
-
Yield 2025 -
14/08 Sagittarius Life Science Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
14/05 Sagittarius Life Science Corp Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
16/03 Sagittarius Life Science Corp Reports Earnings Results for the Full Year Ended December 31, 2025 CI
13/11 Sagittarius Life Science Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
12/25/12 Sagittarius Life Science Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
14/25/14 Sagittarius Life Science Corp Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
13/25/13 Sagittarius Life Science Corp Reports Earnings Results for the Full Year Ended December 31, 2024 CI
14/24/14 Sagittarius Life Science Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
13/24/13 Sagittarius Life Science Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
15/24/15 Sagittarius Life Science Corp Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
21/24/21 Sagittarius Life Science Corp Reports Earnings Results for the Full Year Ended December 31, 2023 CI
14/23/14 Sagittarius Life Science Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
14/23/14 Sagittarius Life Science Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
1 day-0.75%
1 week-1.49%
Current month-1.39%
1 month-1.70%
3 months-7.70%
6 months-22.31%
Current year-10.04%
1 week 46
Extreme 46
47
1 month 45.8
Extreme 45.8
48
Current year 45.8
Extreme 45.8
67
1 year 43.95
Extreme 43.95
67
3 years 21.3
Extreme 21.3
67
5 years 20.65
Extreme 20.65
79.2
10 years 20.65
Extreme 20.65
150
Manager TitleAgeSince
Chief Executive Officer - 30/09/2019
Director of Finance/CFO - 15/11/2019
Director TitleAgeSince
Chairman - 29/04/2004
Director/Board Member - 17/06/2015
Director/Board Member - 29/04/2004
Change 5-day change 1-year change 3-year change Capi.($)
-0.75%-1.49%-15.32%+6.83% 9.56Cr
-0.45%+0.81%+4.16%-15.84% 26TCr
-1.36%-0.65%+2.06%-4.14% 8.14TCr
+3.29%-0.04%+45.39%+549.46% 4.63TCr
-0.55%+2.15%-20.68%+10.14% 4.48TCr
+0.24%-0.22%+29.69%+11.80% 3.86TCr
-1.13%+0.17%-7.80%-11.51% 3.41TCr
-1.01%-5.06%+18.48%+78.75% 3.08TCr
+3.17%-0.26%-10.54%-1.48% 2.97TCr
-0.56%+6.62%-3.46%-22.46% 2.94TCr
Average +0.09%-0.23%+4.20%+60.16% 5.96TCr
Weighted average by Cap. -0.14%+0.47%+5.80%+38.94%

Financials

2024 2025
Net sales 47Cr 1.43Cr 1.28Cr 1.18Cr 1.07Cr 2.01Cr 136.22Cr 2.04Cr 14Cr 5.64Cr 71Cr 5.39Cr 5.27Cr 225.02Cr 35Cr 1.06Cr 94.81L 87.59L 79.37L 1.48Cr 100.79Cr 1.51Cr 11Cr 4.17Cr 53Cr 3.98Cr 3.9Cr 166.48Cr
Net income -4.85Cr -14.89L -13.3L -12.28L -11.13L -20.82L -14Cr -21.17L -1.48Cr -58.52L -7.41Cr -55.88L -54.69L -23Cr -4.96Cr -15.21L -13.58L -12.54L -11.37L -21.27L -14Cr -21.62L -1.51Cr -59.76L -7.56Cr -57.06L -55.85L -24Cr
Net Debt -15Cr -46.06L -41.13L -38L -34.43L -64.42L -44Cr -65.49L -4.57Cr -1.81Cr -23Cr -1.73Cr -1.69Cr -72Cr -80Cr -2.46Cr -2.2Cr -2.03Cr -1.84Cr -3.45Cr -233.9Cr -3.5Cr -24Cr -9.68Cr -122.55Cr -9.25Cr -9.05Cr -386.37Cr
Projected Income Statement - Annual - Sagittarius Life Science Corp
Logo Sagittarius Life Science Corp
Sagittarius Life Science Corp. is a Taiwan-based company principally engaged in the research, development, production and sales of health products. The Company's main products include various types of nutrition and health formulations, natural and organic food, beverages, probiotic fermentation products, beauty care ingredients, Chinese herbal medicines, plant new medicines and health supplies. The Company also provides related technical services for the research and development of Chinese and western pharmaceutical products. The Company distributes its products in domestic market and to overseas markets, such as the rest areas of Asia and the Americas.
Employees
112
Date Price Change Volume
22/26/22 NT$46.15 -0.75% 42,110
21/26/21 NT$46.50 -0.96% 9,324
20/26/20 NT$46.95 +0.32% 8,063
19/26/19 NT$46.80 -0.11% 12,009
  1. Stock Market
  2. Stocks
  3. 3205 Stock